These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 9100602

  • 1. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL, Antunes-Rodrigues J, Elias PC, Moreira AC.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
    [Abstract] [Full Text] [Related]

  • 2. Effect of administration of corticotropin-releasing hormone and glucocorticoid on arginine vasopressin response to osmotic stimulus in normal subjects and patients with hypocorticotropinism without overt diabetes insipidus.
    Yamada K, Tamura Y, Yoshida S.
    J Clin Endocrinol Metab; 1989 Aug; 69(2):396-401. PubMed ID: 2546964
    [Abstract] [Full Text] [Related]

  • 3. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Maccario M, Giordano R, Broglio F, Camanni F, Ghigo E.
    Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
    [Abstract] [Full Text] [Related]

  • 4. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
    Bierwolf C, Burgemeister A, Lüthke K, Born J, Fehm HL.
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1151-7. PubMed ID: 9543132
    [Abstract] [Full Text] [Related]

  • 5. Increases in plasma ACTH and cortisol after hypertonic saline infusion in patients with central diabetes insipidus.
    Itagaki E, Ozawa S, Yamaguchi S, Ushikawa K, Tashiro T, Katahira H, Takizawa M, Yoshimoto K, Murakawa S, Ishida H.
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5749-54. PubMed ID: 11739434
    [Abstract] [Full Text] [Related]

  • 6. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [Abstract] [Full Text] [Related]

  • 7. The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants.
    Ng PC, Wong GW, Lam CW, Lee CH, Wong MY, Fok TF, Wong W, Chan DC.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):797-9. PubMed ID: 9062485
    [Abstract] [Full Text] [Related]

  • 8. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man.
    Rittmaster RS, Cutler GB, Gold PW, Brandon DD, Tomai T, Loriaux DL, Chrousos GP.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):371-6. PubMed ID: 3025246
    [Abstract] [Full Text] [Related]

  • 9. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 10. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 11. Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy.
    Florkowski CM, Crozier IG, Nightingale S, Evans MJ, Ellis MJ, Joyce P, Donald RA.
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):163-8. PubMed ID: 8849570
    [Abstract] [Full Text] [Related]

  • 12. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA, Rebar RW, LaBarbera AR, Pennington EJ, Liu JH.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [Abstract] [Full Text] [Related]

  • 13. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
    Kellner M, Wiedemann K, Holsboer F.
    Life Sci; 1992 Jun; 50(24):1835-42. PubMed ID: 1317939
    [Abstract] [Full Text] [Related]

  • 14. Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.
    Pivonello R, Faggiano A, Filippella M, Di Somma C, De Martino MC, Gaccione M, Lombardi G, Colao A.
    J Endocrinol Invest; 2002 Dec; 25(11):932-7. PubMed ID: 12553551
    [Abstract] [Full Text] [Related]

  • 15. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
    Grottoli S, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, DeStefanis S, Camanni F, Ghigo E, Arvat E.
    J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
    [Abstract] [Full Text] [Related]

  • 16. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man.
    Watabe T, Tanaka K, Kumagae M, Itoh S, Kogure M, Hasegawa M, Horiuchi T, Morio K, Takeda F, Ubukata E.
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1132-7. PubMed ID: 2836468
    [Abstract] [Full Text] [Related]

  • 17. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [Abstract] [Full Text] [Related]

  • 18. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 19. Combined hypervolemia and hypoosmolality alter hypothalamic-pituitary-adrenal axis response to endotoxin stimulation.
    Dadoun F, Velut JG, Guillaume V, Sauze N, Orsoni JC, Gaillard RC, Oliver CC.
    Neuroendocrinology; 1999 May; 69(5):352-9. PubMed ID: 10343176
    [Abstract] [Full Text] [Related]

  • 20. Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism.
    Mortola JF, Rasmussen DD, Yen SS.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):517-22. PubMed ID: 2537336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.